المؤلفون: B. Kilgallen, William A. Wegener, Kenneth C. Kalunian, David M. Goldenberg, Caroline Gordon, Daniel J. Wallace, Vibeke Strand, Kathryn Hobbs, Lexy Kelley, Michelle Petri

المصدر: Rheumatology (Oxford, England)
Rheumatology (Oxford, England), vol 53, iss 3

مصطلحات موضوعية: Male, Internationality, SLE, epratuzumab, Severity of Illness Index, law.invention, corticosteroids, Randomized controlled trial, law, Adrenal Cortex Hormones, Monoclonal, Lupus Erythematosus, Systemic, Pharmacology (medical), Humanized, Pain Measurement, clinical trial, Middle Aged, Clinical Science, Arthralgia, HRQOL, ALLEVIATE, Treatment Outcome, Public Health and Health Services, Female, Drug, medicine.drug, Adult, medicine.medical_specialty, Adolescent, SF-36, Clinical Sciences, Immunology, Placebo, Antibodies, Monoclonal, Humanized, Antibodies, Dose-Response Relationship, Young Adult, Rheumatology, Internal medicine, Statistical significance, Severity of illness, medicine, Humans, CD22, Lupus Erythematosus, Dose-Response Relationship, Drug, business.industry, Systemic, lupus, Interim analysis, Arthritis & Rheumatology, Clinical trial, monoclonal antibody, Physical therapy, Quality of Life, business, Epratuzumab

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec0cb0d662da6d92692206427173812
http://europepmc.org/articles/PMC3930886

المؤلفون: Marilyn C. Pike, Lexy Kelley

المصدر: Current Rheumatology Reports

مصطلحات موضوعية: medicine.medical_specialty, SLE, New agents, MEDLINE, Severity of Illness Index, Inflammatory bowel disease, Systemic Lupus Erythematosus (Jt Merrill, Section Editor), Systemic lupus erythematosus, Optimize, Rheumatology, Internal medicine, medicine, Humans, Immunologic Factors, Lupus Erythematosus, Systemic, Molecular Targeted Therapy, Challenge, Intensive care medicine, Trials, Clinical Trials as Topic, Lupus erythematosus, business.industry, Multiple sclerosis, Data quality, Central adjudication committees, Translational medicine, medicine.disease, Research Design, Rheumatoid arthritis, Immunology, Therapy, Disease Activity Index, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ab992e41bdd6a7641d906088fefc50
https://doi.org/10.1007/s11926-012-0261-7

المؤلفون: Daniel J. Wallace, Vibeke Strand, Frédéric Houssiau, B. Kilgallen, Michelle Petri, Caroline Gordon, Lexy Kelley, Marilyn C. Pike, Kenneth C. Kalunian, S. Bongardt, Anna Barry

المساهمون: UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie

المصدر: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, Vol. 73, no. 1, p. 183-190 (2013)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Treatment outcome, Placebo, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Systemic Lupus Erythematosus, General Biochemistry, Genetics and Molecular Biology, Double blind, Placebos, Rheumatology, Double-Blind Method, immune system diseases, Internal medicine, Severity of illness, medicine, Immunology and Allergy, Humans, Lupus Erythematosus, Systemic, In patient, skin and connective tissue diseases, B-Lymphocytes, B cells, business.industry, Dosing regimen, Middle Aged, Clinical and Epidemiological Research, medicine.disease, Connective tissue disease, 3. Good health, Surgery, Treatment, Treatment Outcome, Female, business, Epratuzumab, Immunosuppressive Agents, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c41350b368609a2618146fd1a58509b
https://pubmed.ncbi.nlm.nih.gov/23313811